Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review
Authors: Raffaelli et al.
Posted in Papers / Reviews /Â January 16-31, 2023
Cephalalgia. 2023 Feb;43(2):3331024221137091.
PMID: 36718044 | DOI: 10.1177/03331024221137091
Share this article
Sign Up For An MSC Newsletter
Sign Up for MSC Content Alerts!
Receive immediate notification when a new piece of content is published on MSC! You can sign up for new article alerts, new literature recap alerts, and/or our monthly newsletter. Visit here to sign up.